Rapport Therapeutics Raises More Than $400 Million in Financing

Rapport Therapeutics closed financings on October 30, including a public stock and pre-funded warrant offering, $172.5 million of convertible notes and a $30 million private placement. It estimates net proceeds of approximately $215.7 million from the stock offering.